---
document_datetime: 2024-08-16 14:49:06
document_pages: 31
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/insuman-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: insuman-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 19.0391365
conversion_datetime: 2025-12-26 10:08:25.41819
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Insuman

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                 | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                           |
|----------------------|---------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------------------------------|
| N/0151               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                      | 14/08/2024                          |                                             | PL                               |                                   |
| PSUSA/1753/ 202310   | Periodic Safety Update EU Single assessment - insulin human, insulin human / insulin isophane (subcutaneous and intravenous routes of | 13/06/2024                          | n/a                                         |                                  | PRAC Recommendation - maintenance |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                     | administration)                                                                                                                                                                                                                                                                                             |            |            |                        |                                   |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------|
| PSUSA/10107 /202309 | Periodic Safety Update EU Single assessment - insulin human (Intraperitoneal use only)                                                                                                                                                                                                                      | 16/05/2024 | n/a        |                        | PRAC Recommendation - maintenance |
| II/0146             | Please refer to the Recommendations section B.II.b.3.b - Change in the manufacturing process of the finished or intermediate product - Substantial changes to a manufacturing process that may have a significant impact on the quality, safety and efficacy of the medicinal product                       | 11/04/2024 | n/a        |                        |                                   |
| IB/0148/G           | This was an application for a group of variations. B.I.c.2.z - Change in the specification parameters and/or limits of the immediate packaging of the AS - Other variation B.I.c.2.z - Change in the specification parameters and/or limits of the immediate packaging of the AS - Other variation          | 30/01/2024 | n/a        |                        |                                   |
| IA/0144             | B.II.e.5.b - Change in pack size of the finished product - Deletion of a pack size(s)                                                                                                                                                                                                                       | 11/07/2023 | 11/09/2023 | SmPC, Labelling and PL |                                   |
| II/0142             | Submission of the final report from study HUBIN-C- 06380 listed as a category 3 study in the RMP. This is an observational prospective PASS designed to gain additional longitudinal and long term safety data related to the use of Insuman Implantable 400 IU/mL via an IP implantable pump in a European | 09/02/2023 | n/a        |                        | Not applicable                    |

<div style=\"page-break-after: always\"></div>

|                     | observational cohort of patients with type 1 diabetes. The updated RMP version 5.0 was agreed during the procedure. C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority   |            |            |      |                                   |
|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------|-----------------------------------|
| IG/1551             | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                                    | 02/12/2022 | n/a        |      |                                   |
| IB/0141             | B.II.f.1.z - Stability of FP - Change in the shelf-life or storage conditions of the finished product - Other variation                                                                                                                                             | 01/09/2022 | 11/09/2023 | SmPC |                                   |
| N/0140              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                    | 07/12/2021 | 11/09/2023 | PL   |                                   |
| PSUSA/1753/ 202010  | Periodic Safety Update EU Single assessment - insulin human, insulin human / insulin isophane (subcutaneous and intravenous routes of administration)                                                                                                               | 10/06/2021 | n/a        |      | PRAC Recommendation - maintenance |
| IB/0139             | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                    | 26/05/2021 | n/a        |      |                                   |
| PSUSA/10107 /202009 | Periodic Safety Update EU Single assessment - insulin human (Intraperitoneal use only)                                                                                                                                                                              | 06/05/2021 | n/a        |      | PRAC Recommendation - maintenance |

<div style=\"page-break-after: always\"></div>

| N/0135    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 21/10/2020   | 20/08/2021   | PL                    |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|-----------------------|
| IA/0136   | B.II.b.5.c - Change to in-process tests or limits applied during the manufacture of the finished product - Deletion of a non-significant in-process test                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 20/10/2020   | n/a          |                       |
| IG/1282   | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 15/09/2020   | n/a          |                       |
| IAIN/0133 | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 10/08/2020   | 20/08/2021   | SmPC, Annex II and PL |
| N/0132    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 17/03/2020   | 20/08/2021   | PL                    |
| II/0130   | Submission of the final report from a completed Phase 3 study, HUBIN-L-05335, listed as a category 3 post-authorisation efficacy / safety study in the RMP. This study covers the evaluation of Insuman Implantable 400 IU/mL in patients with Type 1 diabetes treated with the Medtronic MiniMed Implantable Pump System using Insuplant 400 IU/mL, addressing the Post-Authorisation Measure MEA040. In this application, the RMP v4.1 combines the updates related to HUBIN-L-05335 study final results and the approval of amended protocol V2 of the ongoing Post Authorization Safety Study HUBIN-C- 06380 (MEA/047.4 & MEA/047.5, concerning PRAC decision: EMA/PRAC/256519/2018 dated 17-May- | 03/10/2019   | n/a          |                       |

<div style=\"page-break-after: always\"></div>

|           | 2018; updates are limited to Annex 3 of Part VII). C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority                                                                                                                                                                         |            |            |                        |                    |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|--------------------|
| IA/0131   | A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or novel excipient                                                                                                                                               | 11/09/2019 | n/a        |                        | manufacturer of a  |
| II/0128/G | This was an application for a group of variations. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.b - Changes in the manufacturing process of the AS - Substantial change to the manufacturing process of the AS which may have a significant impact on the quality, safety or efficacy of the | 16/05/2019 | n/a        |                        | medicinal product  |
| IAIN/0129 | B.IV.1.b - Change of a measuring or administration device - Deletion of a device                                                                                                                                                                                                                                                                                         | 23/04/2019 | 08/04/2020 | SmPC, Labelling and PL |                    |
| IG/0999/G | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder AS, starting material, reagent or                                                                                                                                                                                 | 20/11/2018 | n/a        |                        | or supplier of the |

<div style=\"page-break-after: always\"></div>

| intermediate used in the manufacturer of a novel A.4 - Administrative change and/or address of a manufacturer or supplier of the AS, starting intermediate used in the manufacturer of a novel A.4 - Administrative change and/or address of a manufacturer or supplier of the AS, starting intermediate used in the manufacturer of a novel A.4 - Administrative change and/or address of a manufacturer or supplier of the AS, starting intermediate used in the manufacturer of a novel A.4 - Administrative change and/or address of a manufacturer or supplier of the AS, starting intermediate used in the manufacturer of a novel A.4 - Administrative change and/or address of a manufacturer or supplier of the AS, starting intermediate used in the manufacturer of a novel A.4 - Administrative change and/or address of a manufacturer or supplier of the AS, starting intermediate used in the   |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

| IB/0125             | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                                                                          | 02/08/2018   | n/a        |                        |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|
| PSUSA/1753/ 201710  | Periodic Safety Update EU Single assessment - insulin human, insulin human / insulin isophane (subcutaneous and intravenous routes of administration)                                                                                               | 14/06/2018   | n/a        |                        |
| II/0124             | B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change outside the approved specifications limits range                                                                                                 | 31/05/2018   | n/a        |                        |
| IB/0123             | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                                                                          | 24/04/2018   | n/a        |                        |
| PSUSA/10107 /201709 | Periodic Safety Update EU Single assessment - insulin human (Intraperitoneal use only)                                                                                                                                                              | 12/04/2018   | n/a        |                        |
| IB/0122             | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                      | 03/04/2018   | 14/06/2018 | SmPC, Labelling and PL |
| IB/0119             | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                      | 21/02/2018   | 14/06/2018 | SmPC, Labelling and PL |
| IB/0118/G           | This was an application for a group of variations. B.II.e.5.b - Change in pack size of the finished product - Deletion of a pack size(s) B.IV.1.a.1 - Change of a measuring or administration device - Addition or replacement of a device which is | 29/06/2017   | 14/06/2018 | SmPC, Labelling and PL |

<div style=\"page-break-after: always\"></div>

|                     | not an integrated part of the primary packaging - Device with CE marking C.I.7.b - Deletion of - a strength                                                                                                                                                                                                                                                                                                                                                                                     |            |     |                                   |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| II/0117/G           | This was an application for a group of variations. B.II.b.3.b - Change in the manufacturing process of the finished or intermediate product - Substantial changes to a manufacturing process that may have a significant impact on the quality, safety and efficacy of the medicinal product B.II.b.4.d - Change in the batch size (including batch size ranges) of the finished product - The change relates to all other pharmaceutical forms manufactured by complex manufacturing processes | 22/06/2017 | n/a |                                   |
| PSUSA/10107 /201609 | Periodic Safety Update EU Single assessment - insulin human (Intraperitoneal use only)                                                                                                                                                                                                                                                                                                                                                                                                          | 06/04/2017 | n/a | PRAC Recommendation - maintenance |
| IB/0116             | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                                                                                                                                                                                                                                | 24/01/2017 | n/a |                                   |
| IA/0115             | B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter)                                                                                                                                                                                                                                                                             | 14/12/2016 | n/a |                                   |
| II/0112/G           | This was an application for a group of variations. B.II.b.1.c - Replacement or addition of a                                                                                                                                                                                                                                                                                                                                                                                                    | 19/05/2016 | n/a |                                   |

<div style=\"page-break-after: always\"></div>

|                     | manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch release/control, and secondary packaging, for biol/immunol medicinal products or pharmaceutical forms manufactured by complex manufacturing processes B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.3.c - Change in the manufacturing process of the finished or intermediate product - The product is a biological/immunological medicinal product and the change requires an assessment of comparability   |            |            |    |                                   |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----|-----------------------------------|
| N/0113              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 28/04/2016 | 14/06/2018 | PL |                                   |
| PSUSA/10107 /201509 | Periodic Safety Update EU Single assessment - insulin human (Intraperitoneal use only)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 14/04/2016 | n/a        |    | PRAC Recommendation - maintenance |
| IB/0111/G           | This was an application for a group of variations. C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                                                                                                                      | 11/01/2016 | n/a        |    |                                   |
| IA/0109/G           | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 02/10/2015 | n/a        |    |                                   |

<div style=\"page-break-after: always\"></div>

|           | in the specification parameters and/or limits of an excipient - Addition of a new specification parameter to the specification with its corresponding test method B.II.c.2.a - Change in test procedure for an excipient - Minor changes to an approved test procedure B.II.c.2.a - Change in test procedure for an excipient - Minor changes to an approved test procedure                                                                                                                                                                                                                                |            |     | B.II.c.1.b - Change   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------|
| IA/0108/G | This was an application for a group of variations. B.II.c.1.a - Change in the specification parameters and/or limits of an excipient - Tightening of specification limits B.II.c.1.b - Change in the specification parameters and/or limits of an excipient - Addition of a new specification parameter to the specification with its corresponding test method B.II.c.1.c - Change in the specification parameters and/or limits of an excipient - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.II.c.2.a - Change in test procedure for an excipient | 02/10/2015 | n/a | - Minor               |
| IA/0107/G | This was an application for a group of variations. B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.1.d - Change in the specification parameters                                                                                                                                                                                                                                                                                                                                               | 11/08/2015 | n/a |                       |

<div style=\"page-break-after: always\"></div>

|                     | and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter)                                                                                                                                                                                                                                          |            |            |    |                                   |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----|-----------------------------------|
| N/0106              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                          | 21/07/2015 | 14/06/2018 | PL |                                   |
| PSUSA/1753/ 201410  | Periodic Safety Update EU Single assessment - insulin human, insulin human / insulin isophane (subcutaneous and intravenous routes of administration)                                                                                                                                                                                                                                                     | 11/06/2015 | n/a        |    | PRAC Recommendation - maintenance |
| PSUSA/10107 /201409 | Periodic Safety Update EU Single assessment - insulin human (Intraperitoneal use only)                                                                                                                                                                                                                                                                                                                    | 10/04/2015 | n/a        |    | PRAC Recommendation - maintenance |
| IB/0103             | B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data                                                                                                                                                                                                                                    | 16/12/2014 | n/a        |    |                                   |
| II/0102             | Update of the Risk Management Plan (RMP) for Insuman Implantable 400 IU/ml version 2.0 dated 16 July 2014. C.I.11.b - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Implementation of change(s) which require to be further substantiated by new additional data to be submitted by the MAH where significant assessment is required | 20/11/2014 | n/a        |    |                                   |

<div style=\"page-break-after: always\"></div>

| IB/0099   | B.II.e.3.b - Change in test procedure for the immediate packaging of the finished product - Other changes to a test procedure (including replacement or addition)                   | 18/07/2014   | n/a        |                                  |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|
| IG/0454   | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                     | 17/07/2014   | n/a        |                                  |
| IG/0453   | B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect the product information      | 27/06/2014   | n/a        |                                  |
| II/0097   | C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority                                       | 25/04/2014   | n/a        |                                  |
| IG/0427   | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                        | 16/04/2014   | n/a        |                                  |
| IB/0096   | B.IV.1.a.1 - Change of a measuring or administration device - Addition or replacement of a device which is not an integrated part of the primary packaging - Device with CE marking | 05/12/2013   | 03/10/2014 | SmPC, Labelling and PL           |
| X/0091    | Annex I_2.(d) Change or addition of a new pharmaceutical form                                                                                                                       | 25/07/2013   | 19/09/2013 | SmPC, Annex II, Labelling and PL |

<div style=\"page-break-after: always\"></div>

| IB/0095   | B.IV.1.a.1 - Change of a measuring or administration device - Addition or replacement of a device which is not an integrated part of the primary packaging - Device with CE marking                                                                                                                                                                                                     | 17/09/2013   | 03/10/2014   | SmPC, Annex II, Labelling and PL   |                     |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------------------|---------------------|
| IG/0314   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                          | 08/07/2013   | n/a          |                                    |                     |
| IG/0300   | B.II.e.7.a - Change in supplier of packaging components or devices (when mentioned in the dossier) - Deletion of a supplier                                                                                                                                                                                                                                                             | 03/05/2013   | n/a          |                                    |                     |
|           | This was an application for a group of variations. B.II.b.5.b - Change to in-process tests or limits applied during the manufacture of the finished product - Addition of a new tests and limits B.II.b.5.c - Change to in-process tests or limits applied during the manufacture of the finished product - Deletion of a non-significant in-process test                               | 13/12/2012   | n/a          |                                    | IG/0246/G           |
| II/0090/G | This was an application for a group of variations. - To introduce changes in the manufacturing process of the active substance. - To change the immediate packaging of the active substance. - To delete a non-significant in-process test applied during the manufacture of the active substance. B.I.a.2.c - Changes in the manufacturing process of refers to a [-] substance in the | 15/11/2012   | n/a          |                                    | the AS - The change |

<div style=\"page-break-after: always\"></div>

|         | manufacture of a biological/immunological medicinal product and is not related to a protocol B.I.c.1.a - Change in immediate packaging of the AS - Qualitative and/or quantitative composition B.I.a.4.c - Change to in-process tests or limits applied during the manufacture of the AS - Deletion of a non-significant in-process test                                                              |            |            |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IG/0198 | B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits                                                                                                                                                                                                                                                | 27/07/2012 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| WS/0229 | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.II.e.5.c - Change in pack size of the finished product - Change in the fill weight/fill volume of sterile multidose (or single-dose, partial use) parenteral medicinal products, and biological/immunological multidose parenteral medicinal products | 24/05/2012 | 03/07/2012 | SmPC, Labelling and PL           |                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| WS/0208 | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. Update of section 6.6 for SoloStar pre-filled pen presentation for the Insuman, Insuman Human Whintrop, Apidra, Lantus and Optisulin to reinforce the appropriate use of SoloStar. The Package Leaflet                                                  | 15/03/2012 | 20/04/2012 | SmPC, Annex II, Labelling and PL | Update of the labelling documents for three sanofi-aventis insulins is proposed in this type II variation to reinforce the appropriate use of Solostar prefilled pen. This update is based on the experience gained since 2006 (e.g. following reports and questions raised by the pen users) and a continued evaluation of possible improvements of the Product Information. During this period a number of product technical complaints |

<div style=\"page-break-after: always\"></div>

|           | was proposed to be updated in accordance. Furthermore, the MAH proposed this opportunity to bring the PI in line with latest QRD template version 8.0 for Insuman, Apidra, Lantus and Optisulin. C.I.4 - Variations related to significant modifications of the SPC due in particular to new quality, pre- clinical, clinical or pharmacovigilance data                                                                                     |            |     | were received concerning the functionality of the pen, namely a blocked pen, where it is impossible to dial or inject a dose. The cause was identified that when dialling a dose and pushing the dose button without a needle attached to the pen, a mechanical pressure within the system builds, leading to a blockage of the pen mechanism. For this reason the Instructions for Use are updated to make the patient aware not to dial a dose or push the dose button without having a needle attached. There was no technical change made to the Solostar prefilled pen.   |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IG/0158/G | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                | 28/03/2012 | n/a |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| IG/0147/G | This was an application for a group of variations. C.I.9.c - Changes to an existing pharmacovigilance system as described in the DDPS - Change of the back-up procedure of the QPPV C.I.9.e - Changes to an existing pharmacovigilance system as described in the DDPS - Changes in the major contractual arrangements with other persons or organisations involved in the fulfilment of pharmacovigilance obligations and described in the | 29/02/2012 | n/a |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

<div style=\"page-break-after: always\"></div>

|         | C.I.9.f - Changes to an existing pharmacovigilance system as described in the DDPS - Deletion of topics covered by written procedure(s) describing pharmacovigilance activities C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of pharmacovigilance system                                                                                                                                          |            |            | DD the   |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------|
| IG/0091 | C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of the pharmacovigilance system                                                                                                                                                                                                                                                                                                                      | 05/07/2011 | n/a        |          |
| IA/0082 | B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter)                                                                                                                                                                                                                                                                                         | 01/06/2011 | n/a        |          |
| II/0081 | Changes to the cleaning procedure of the bioreactor used at Step 3 (main fermentation) of the manufacturing process of the active substance (lower the temperature and incubation time (from >/=121C for >/= 45 min to >/= 60 C for >/= 30 min) for the treatment with sodium hydroxide solution). Minor editorial corrections in Module S.2 B.I.a.2.c - Changes in the manufacturing process of the AS - The change refers to a [-] substance in the manufacture of a biological/immunological medicinal | 19/05/2011 | 19/05/2011 |          |

<div style=\"page-break-after: always\"></div>

|         | product and is not related to a protocol                                                                                                                                                                                                        |            |            |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0077 | Update of product information to reflect the risk of medication errors (insulin mix-up). C.I.4 - Variations related to significant modifications of the SPC due in particular to new quality, pre- clinical, clinical or pharmacovigilance data | 16/12/2010 | 01/02/2011 | SmPC, Annex II, Labelling and PL | The portfolio of the MAH contains several different insulins with several insulin delivery devices (IDD), including the re- usable devices (OptiPen Pro and OptiClik) and the device/drug combinations (pre-filled disposable pens OptiSet and SoloStar). The complexity regarding the various insulin treatments used in a single diabetic patient, (i.e. long acting, rapid acting; with the latter needing to be administered multiple times a day) in order to achieve optimal glycaemia control has created a situation wherein product differentiation becomes increasingly important. Adverse events associated with insulins mix-ups, often result in massive overdose of the rapid-acting insulin which may subsequently lead to hypoglycaemia, which if left untreated may be life-threatening, or result in death. In most cases, however, the patients noticed the mistake and took measures to avoid hypoglycaemia, which may explain the large number of cases with no AE or non-serious cases. In order to mitigate the risk of medication errors, the MAH has focused its efforts up to now on educational activities to ensure the safe administration of their insulins. The MAH has also focused on differentiation strategies for insulin products to mitigate the potential risk of administering the wrong insulin to a person with diabetes. The product information for all the insulins from this MAH has been updated through the present variation to include warnings on the risk of insulin mix-up. Additionally, the MAH will incorporate changes to the existing insulins packaging. The aim of these changes is to better differentiate the different products and to increase |

<div style=\"page-break-after: always\"></div>

|           |                                                                                                                                                                                                                                                                                                                               |            |     |                        | readability for the pharmacist, Health Care Professional or patient in order to reduce potential mix-ups.   |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------------------------|-------------------------------------------------------------------------------------------------------------|
| IB/0080   | C.I.3.a - Implementation of change(s) requested following the assessment of an USR, class labelling, a PSUR, RMP, FUM/SO, data submitted under A 45/46, or amendments to reflect a Core SPC - Changes with NO new additional data are submitted by the MAH                                                                    | 19/01/2011 | n/a | SmPC and PL            |                                                                                                             |
| IA/0079   | B.II.e.2.c - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Deletion of a non-significant specification parameter (e.g. deletion of an obsolete parameter)                                                                                                         | 20/12/2010 | n/a |                        |                                                                                                             |
| IB/0078   | Change in the Product Information (SmPC, L and PL) to include the name of the re-usable pens to be used with the cartridge presentations. B.IV.1.a.1 - Change of a measuring or administration device - Addition or replacement of a device which is not an integrated part of the primary packaging - Device with CE marking | 19/11/2010 | n/a | SmPC, Labelling and PL |                                                                                                             |
| IA/0075/G | This was an application for a group of variations. B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a Member State                                                      | 18/08/2010 | n/a |                        |                                                                                                             |

<div style=\"page-break-after: always\"></div>

|           | the manufacture of the AS - of in-process limits - Change in the specification parameters limits of an AS, starting material/intermediate/reagent - Deletion of a non- specification parameter (e.g. deletion of obsolete parameter)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |            |     |          | applied during Tightening B.I.b.1.d and/or significant an   |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----------|-------------------------------------------------------------|
| IG/0004/G | was an application for a group of variations. C.I.9.a - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the QPPV C.I.9.b - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the contact details of the QPPV C.I.9.c - Changes to an existing pharmacovigilance system as described in the DDPS - Change of the back-up procedure of the QPPV C.I.9.d - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the safety database C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of the pharmacovigilance system | 06/05/2010 | n/a | Annex II | This                                                        |
| IA/0074   | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 23/04/2010 | n/a |          |                                                             |

<div style=\"page-break-after: always\"></div>

| II/0070   | Update and transfer of the existing information on switching patients between different Sanofi-Aventis Deutschland GmbH insulins from section 4.2 to section 4.4 of the SPC. Update of the pharmacotherapeutic group in section 5.1 of the SPC to comply with the latest QRD template. Minor wording changes introduced in annex IIIA (for the presentations cartridge, cartridge for Opticlick, pre- filled pen Optiset and pre-filled pen SoloStar). Update to the instructions for use of the Optiset pre- filled pen presentations in the Package Leaflet. Update of the contact details of the local representatives for Poland and Italy in the Package Leaflet for all presentations. Update of Summary of Product Characteristics, Labelling and Package Leaflet   | 24/09/2009   | 11/11/2009   | SmPC, Labelling and PL   | Section 4.4 of the SPC was updated in order to harmonise the information between all Sanofi-Aventis Deutschland GmbH insulins regarding the transfer of patients from one insulin to another in order to improve the information given to the prescriber and to answer questions raised concerning the adjustment of the dose needed this specific transition period. Section 5.1 of the SPC was updated to comply with the latest version of the QRD template for the SPC. Minor changes were introduced in the Labelling to harmonise the information between all Sanofi-Aventis Deutschland GmbH insulins and in the wording of the OptiSet User Manual (located at the end of the Package Leaflet) for quality purposes.   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|--------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0073   | Change to a test procedure of the immediate packaging of the finished product. IB_27_b_Change to test proc. of immediate packaging - other changes (incl. replacement/addition)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 11/11/2009   | n/a          |                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| IB/0072   | Change in a test procedure of the finished product IB_38_b_Change in test procedure of finished product - minor change, biol. active subst./excipient                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 11/11/2009   | n/a          |                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| IB/0067   | IB_38_c_Change in test procedure of finished product - other changes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 04/08/2009   | n/a          |                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

<div style=\"page-break-after: always\"></div>

| IB/0069   | IB_30_b_Change in supplier of packaging components - replacement/addition                                                                                         | 29/06/2009   | n/a        |                        |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|
| II/0066   | Addition of new presentations New presentation(s)                                                                                                                 | 23/04/2009   | 29/05/2009 | SmPC, Labelling and PL |
| X/0057    | Annex I_2.(c) Change or addition of a new strength/potency                                                                                                        | 23/10/2008   | 19/02/2009 | SmPC, Labelling and PL |
| IB/0065   | IB_38_c_Change in test procedure of finished product - other changes                                                                                              | 12/02/2009   | n/a        |                        |
| II/0064   | Extension of shelf-life of the drug substance. Change(s) to shelf-life or storage conditions                                                                      | 22/01/2009   | 28/01/2009 |                        |
| II/0060   | Replacement of reagents and minor adjustments of the manufacturing process of the drug substance. Change(s) to the manufacturing process for the active substance | 20/11/2008   | 26/11/2008 |                        |
| II/0059   | Addtion of new presentations New presentation(s)                                                                                                                  | 25/09/2008   | 04/11/2008 | SmPC, Labelling and PL |
| IB/0063   | IB_38_b_Change in test procedure of finished product - minor change, biol. active subst./excipient                                                                | 26/09/2008   | n/a        |                        |

<div style=\"page-break-after: always\"></div>

| IB/0062   | IB_38_b_Change in test procedure of finished product - minor change, biol. active subst./excipient                                 | 24/09/2008   | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                                                                                             |
|-----------|------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0061   | IA_38_a_Change in test procedure of finished product - minor change to approved test procedure                                     | 12/09/2008   | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                                                                                             |
| II/0056   | Update of Summary of Product Characteristics and Package Leaflet. Update of Summary of Product Characteristics and Package Leaflet | 24/04/2008   | 18/06/2008 | SmPC and PL            | Update of the Product Information (PI) to harmonise the SPC and PL of the sanofi-aventis insulin containing products (insuline glargine, insulin glulisine and insulin human). Particularly for Insulin human, the SPC has been revised and the Package Leaflet has been updated to reflect the outcome of the user Readability User Testing performed to demonstrate the readability and usefulness of the PL to patients. |
| IB/0058   | IB_38_c_Change in test procedure of finished product - other changes                                                               | 26/02/2008   | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                                                                                             |
| II/0053   | Change(s) to the test method(s) and/or specifications for the active substance                                                     | 24/01/2008   | 30/01/2008 |                        |                                                                                                                                                                                                                                                                                                                                                                                                                             |
| II/0055   | The Marketing Authorisation Holder applied for the addition of a new presentation: cartridge for Opticlick. New presentation(s)    | 15/11/2007   | 18/12/2007 | SmPC, Labelling and PL |                                                                                                                                                                                                                                                                                                                                                                                                                             |
| IA/0054   | IA_38_a_Change in test procedure of finished product - minor change to approved test procedure                                     | 06/08/2007   | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                                                                                             |
| IB/0032   | IB_41_a_02_Change in pack size - change in no. of units outside range of appr. pack size                                           | 25/07/2007   | 25/07/2007 | SmPC, Labelling and    |                                                                                                                                                                                                                                                                                                                                                                                                                             |

<div style=\"page-break-after: always\"></div>

|         |                                                                                          |            |            | PL                     |
|---------|------------------------------------------------------------------------------------------|------------|------------|------------------------|
| IB/0031 | IB_41_a_02_Change in pack size - change in no. of units outside range of appr. pack size | 25/07/2007 | 25/07/2007 | SmPC, Labelling and PL |
| IB/0030 | IB_41_a_02_Change in pack size - change in no. of units outside range of appr. pack size | 25/07/2007 | 25/07/2007 | SmPC, Labelling and PL |
| IB/0029 | IB_41_a_02_Change in pack size - change in no. of units outside range of appr. pack size | 25/07/2007 | 25/07/2007 | SmPC, Labelling and PL |
| IB/0028 | IB_41_a_02_Change in pack size - change in no. of units outside range of appr. pack size | 25/07/2007 | 25/07/2007 | SmPC, Labelling and PL |
| IA/0052 | IA_41_a_01_Change in pack size - change in no. of units within range of appr. pack size  | 25/07/2007 | 10/10/2007 | SmPC, Labelling and PL |
| IA/0051 | IA_41_a_01_Change in pack size - change in no. of units within range of appr. pack size  | 25/07/2007 | 25/07/2007 | SmPC, Labelling and PL |
| IA/0050 | IA_41_a_01_Change in pack size - change in no. of units within range of appr. pack size  | 25/07/2007 | 25/07/2007 | SmPC, Labelling and PL |
| IA/0049 | IA_41_a_01_Change in pack size - change in no. of units within range of appr. pack size  | 25/07/2007 | 25/07/2007 | SmPC, Labelling and PL |
| IA/0048 | IA_41_a_01_Change in pack size - change in no. of units within range of appr. pack size  | 25/07/2007 | 25/07/2007 | SmPC, Labelling and    |

<div style=\"page-break-after: always\"></div>

|         |                                                                                         |            |            | PL                     |
|---------|-----------------------------------------------------------------------------------------|------------|------------|------------------------|
| IA/0047 | IA_41_a_01_Change in pack size - change in no. of units within range of appr. pack size | 25/07/2007 | 25/07/2007 | SmPC, Labelling and PL |
| IA/0046 | IA_41_a_01_Change in pack size - change in no. of units within range of appr. pack size | 25/07/2007 | 25/07/2007 | SmPC, Labelling and PL |
| IA/0045 | IA_41_a_01_Change in pack size - change in no. of units within range of appr. pack size | 25/07/2007 | 25/07/2007 | SmPC, Labelling and PL |
| IA/0044 | IA_41_a_01_Change in pack size - change in no. of units within range of appr. pack size | 25/07/2007 | 25/07/2007 | SmPC, Labelling and PL |
| IA/0043 | IA_41_a_01_Change in pack size - change in no. of units within range of appr. pack size | 25/07/2007 | 25/07/2007 | SmPC, Labelling and PL |
| IA/0042 | IA_41_a_01_Change in pack size - change in no. of units within range of appr. pack size | 25/07/2007 | 25/07/2007 | SmPC, Labelling and PL |
| IA/0041 | IA_41_a_01_Change in pack size - change in no. of units within range of appr. pack size | 25/07/2007 | 25/07/2007 | SmPC, Labelling and PL |
| IA/0040 | IA_41_a_01_Change in pack size - change in no. of units within range of appr. pack size | 25/07/2007 | 25/07/2007 | SmPC, Labelling and PL |
| IA/0039 | IA_41_a_01_Change in pack size - change in no. of units within range of appr. pack size | 25/07/2007 | 25/07/2007 | SmPC, Labelling and    |

<div style=\"page-break-after: always\"></div>

|         |                                                                                                  |            |            | PL                               |                                                                                                                                                                                                                                                                                                                                                                                                     |
|---------|--------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0038 | IA_41_a_01_Change in pack size - change in no. of units within range of appr. pack size          | 25/07/2007 | 25/07/2007 | SmPC, Labelling and PL           |                                                                                                                                                                                                                                                                                                                                                                                                     |
| IA/0037 | IA_41_a_01_Change in pack size - change in no. of units within range of appr. pack size          | 25/07/2007 | 25/07/2007 | SmPC, Labelling and PL           |                                                                                                                                                                                                                                                                                                                                                                                                     |
| IA/0036 | IA_41_a_01_Change in pack size - change in no. of units within range of appr. pack size          | 25/07/2007 | 25/07/2007 | SmPC, Labelling and PL           |                                                                                                                                                                                                                                                                                                                                                                                                     |
| IA/0035 | IA_41_a_01_Change in pack size - change in no. of units within range of appr. pack size          | 25/07/2007 | 25/07/2007 | SmPC, Labelling and PL           |                                                                                                                                                                                                                                                                                                                                                                                                     |
| IA/0034 | IA_41_a_01_Change in pack size - change in no. of units within range of appr. pack size          | 25/07/2007 | 25/07/2007 | SmPC, Labelling and PL           |                                                                                                                                                                                                                                                                                                                                                                                                     |
| IA/0033 | IA_41_a_01_Change in pack size - change in no. of units within range of appr. pack size          | 25/07/2007 | 25/07/2007 | SmPC, Labelling and PL           |                                                                                                                                                                                                                                                                                                                                                                                                     |
| R/0025  | Renewal of the marketing authorisation.                                                          | 16/11/2006 | 16/01/2007 | SmPC, Annex II, Labelling and PL | Based on the review of the available information the CHMP is of the opinion that the quality, the safety and the efficacy of this medicinal product continues to be adequately and sufficiently demonstrated and therefore considers that the benefit/risk profile of Insuman continues to be favourable. The CHMP was also of the opinion that the renewal can be granted with unlimited validity. |
| II/0027 | Update of Summary of Product Characteristics and Package Leaflet of the Optiset presentations to | 21/09/2006 | 31/10/2006 | SmPC and PL                      | After the experience gained from the users through user surveys and outside experts consultation, the MAH has                                                                                                                                                                                                                                                                                       |

<div style=\"page-break-after: always\"></div>

|         | reflect a revision of the Optiset Instructions for Use. Update of Summary of Product Characteristics and Package Leaflet                                                                                                                                           |            |            |                                  | proposed to revise the Optiset Instructions for Use and the Summary of Product Characteristics of the Optiset presentations for Insuman. The MAH has performed a readability test that shows that the revised manual complies with the standard acceptance criteria (80% of participants were able to find the information requested in the PL and instructions for use manual and could show that they understand it).                                                                                                                                                                                                                        |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0026 | IB_25_a_02_Change to comply with Ph. - compliance with EU Ph. - excipient                                                                                                                                                                                          | 27/07/2006 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| IA/0024 | IA_01_Change in the name and/or address of the marketing authorisation holder IA_04_Change in name and/or address of a manuf. of the active substance (no Ph. Eur. cert. avail.) IA_05_Change in the name and/or address of a manufacturer of the finished product | 01/06/2006 | n/a        | SmPC, Annex II, Labelling and PL |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| II/0023 | Change(s) to (an) ancillary medical device(s) Change(s) to (an) ancillary medical device(s)                                                                                                                                                                        | 23/03/2006 | 05/05/2006 | SmPC, Labelling and PL           | Modifications to the OptiSet pen and imprinting the name of the insulin on the pen for identification. The purpose of this change is to implement technical improvements to OptiSet in order to prevent mishandling of the pen and thus to improve the safety of the device, particularly when it is wrongly used. In addition, the trade name of the insulin will be printed on the pen, to enable a complete differentiation from other insulins provided with the OptiSet pen. The data provided was adequate and satisfactory and the proposed changes were acceptable. The instructions for use of the pen have been updated accordingly. |

<div style=\"page-break-after: always\"></div>

| II/0022   | Change(s) to container                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 26/01/2006   | 14/02/2006   | SmPC                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0021   | The Marketing Authorisation Holder applied for changes at steps 8 (folding and precipitation of by- products), 9 (tryptic cleavage) and 12 (carboxypeptidase B cleavage) of the manufacturing process of the active substance. Change(s) to the manufacturing process for the active substance                                                                                                                                                                                                                                                                                                                            | 23/06/2005   | 30/06/2005   |                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| II/0020   | Update of sections 4.2, 4.4, 6.6 of the Summary of Product Characteristics to include additional warnings for the use of the OptiSet device and update of the Package Leaflet including a complete revision of the instructions for the use of Insuman OptiSet. Addition of a caution statement to the outer carton. In addition the MAH applied to include a storage precaution with regard to the first use of Insuman Optiset in section 6.4 of the SPC and to include minor linguistic changes in the SPC, Labelling and Package Leaflet. Update of Summary of Product Characteristics, Labelling and Package Leaflet | 29/07/2004   | 24/09/2004   | SmPC, Labelling and PL | The MAH applied for this variation to update sections 4.2, 4.4 and 6.6 of the SPC to include additional warnings for the use of the OptiSet device and to highlight the most important handling steps for the use of the OptiSet in a more prominent way. In the SPC it was highlighted in sections 4.2 (paragraph administration) and in section 4.4 (addition of specific paragraph \"handling of the pen\") that the instructions for use included in the package leaflet must be read carefully before use and that Optiset has to be used as recommended in these instructions. More details about the use of the pen have been introduced in section 6.6. The Package Leaflet has been revised accordingly to improve clarity. The instructions for the use of Insuman OptiSet has been completely revised. A caution statement has been added to the outer carton. |
| II/0019   | Update of section 6.6 of the Summary of Product Characteristics to include instructions and warnings for handling the OptiPen in case of mechanical defects.                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 23/06/2004   | 04/08/2004   | SmPC, Labelling and PL | Following reports received from patients who had experienced difficulties with insulin administration by OptiPen the CHMP concluded at the March 2004 plenary meeting that the Product Information for Insuman cartridges should be amended to include a warning in the                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |

<div style=\"page-break-after: always\"></div>

|         | Update of Summary of Product Characteristics, Labelling and Package Leaflet                                                                                                                                                                                                                                                  |            |            |             | Product Information describing that Optipen should not be used in case of mechanical defects. Some devices were investigated after the reported failure and the manufacturer's reports conclude in a suspected user's failure rather than a device failure. Information was added to section 6.6 of the SPC (cartridge presentations). This information was also added to the labelling the outer packaging as well as clarification that the cartridges are to be used in conjunction with an insulin pen such as OptiPen and other pens suitable for Insuman cartridges. To section 3 of the Package Leaflet was added the advice to follow the manufacturer's instructions for using the pen carefully for loading the cartridge, attaching the needle, and administering the insulin injection, to see instructions for using the pen and not to use OptiPen if it is   |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0018 | The Marketing Authorisation Holder applied for the omission of routine sterility testing of the container closure system for Insuman Infusat cartridges. Change(s) to the test method(s) and/or specifications for the finished product                                                                                      | 22/04/2004 | 27/04/2004 |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| II/0015 | Update of section 4.4 of the Summary of Product Characteristics (SPC) and section 4 of the Package Leaflet to include a class warning regarding hypoglycaemic reactions after transfer from animal source insulin to human insulins. In addition the MAH applied to update the local representatives in the Package Leaflet. | 24/07/2003 | 24/10/2003 | SmPC and PL | The CHMP requested an update of section 4.4 of the SPC to include a class labelling for all centrally authorised human insulins relating to hypoglycaemic reactions after transfer from animal source insulin to human insulin. This information was added to section 4.4. of the SPC and section 4 of the Package Leaflet.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |

<div style=\"page-break-after: always\"></div>

|         | of Summary of Product Characteristics and Leaflet                                                                                                                                                                                                                                                                             |            |            |                                  | Update Package   |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|------------------|
| I/0016  | 12_Minor change of manufacturing process of the active substance                                                                                                                                                                                                                                                              | 25/09/2003 | 02/10/2003 |                                  |                  |
| I/0017  | 11b_Change in supplier of an intermediate compound used in manufacture of the active substance                                                                                                                                                                                                                                | 01/08/2003 | 05/09/2003 |                                  |                  |
| II/0014 | Change(s) to the test method(s) and/or specifications for the finished product                                                                                                                                                                                                                                                | 25/04/2002 | 30/04/2002 |                                  |                  |
| R/0013  | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                       | 13/12/2001 | 22/03/2002 | SmPC, Annex II, Labelling and PL |                  |
| I/0012  | 17_Change in specification of the medicinal product                                                                                                                                                                                                                                                                           | 12/12/2001 | n/a        |                                  |                  |
| II/0009 | Update of Summary of Product Characteristics and Package Leaflet                                                                                                                                                                                                                                                              | 14/12/2000 | 14/06/2001 | SmPC, Labelling and PL           |                  |
| I/0010  | Change of the name of the Marketing Authorisation Holder from Hoechst Marion Roussel Deutschland GmbH to Aventis Pharma Deutschland GmbH. This name change results in two consequential changes (i) in the name of the manufacturer of the active substance and ii) in the name of the manufacturer of the medicinal product. | 21/12/2000 | 14/06/2001 | SmPC, Annex II, Labelling and PL | 03_Change        |

<div style=\"page-break-after: always\"></div>

|         | marketing authorisation holder 01_Change following modification(s) of the manufacturing authorisation(s) 11a_Change in the name of a manufacturer of the active substance   |            |            |                                  |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|
| II/0011 | Update of or change(s) to the pharmaceutical documentation                                                                                                                  | 26/04/2001 | 04/05/2001 |                                  |
| II/0008 | Quality changes                                                                                                                                                             | 19/10/2000 | 15/11/2000 |                                  |
| I/0007  | 24_Change in test procedure of active substance                                                                                                                             | 19/10/2000 | 15/11/2000 |                                  |
| X/0003  | X-3-v_Addition of a new route of administration                                                                                                                             | 20/01/2000 | 01/08/2000 | SmPC, Annex II, Labelling and PL |
| II/0006 | Quality changes                                                                                                                                                             | 13/04/2000 | 28/04/2000 |                                  |
| II/0004 | New presentation(s)                                                                                                                                                         | 18/11/1999 | 20/03/2000 | SmPC, Labelling and PL           |
| II/0005 | Change(s) to the manufacturing process for the finished product                                                                                                             | 20/01/2000 | 22/02/2000 |                                  |
| II/0002 | New presentation(s)                                                                                                                                                         | 16/12/1999 | 18/02/1999 | SmPC, Labelling and PL           |
| II/0001 | New presentation(s)                                                                                                                                                         | 16/12/1998 | 18/02/1999 | SmPC, Labelling and PL           |